Pavmed Inc Stock Price on October 28, 2024
PAVM Stock | USD 0.76 0.02 1.97% |
Below is the normalized historical share price chart for PAVmed Inc extending back to July 28, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of PAVmed stands at 0.76, as last reported on the 13th of December 2024, with the highest price reaching 0.76 and the lowest price hitting 0.76 during the day.
If you're considering investing in PAVmed Stock, it is important to understand the factors that can impact its price. PAVmed Inc maintains Sharpe Ratio (i.e., Efficiency) of -0.19, which implies the company had a -0.19% return per unit of standard deviation over the last 3 months. PAVmed Inc exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check PAVmed's Market Risk Adjusted Performance of (5.63), mean deviation of 4.34, and Variance of 33.71 to confirm the risk estimate we provide.
At this time, PAVmed's Common Stock Total Equity is very stable compared to the past year. As of the 13th of December 2024, Other Stockholder Equity is likely to grow to about 249.5 M, while Common Stock Shares Outstanding is likely to drop about 6.9 M. . As of the 13th of December 2024, Price Earnings To Growth Ratio is likely to grow to 0.01, while Price To Sales Ratio is likely to drop 11.54. PAVmed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of April 2016 | 200 Day MA 1.3965 | 50 Day MA 1.0713 | Beta 0.693 |
PAVmed |
Sharpe Ratio = -0.1939
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | PAVM |
Estimated Market Risk
5.78 actual daily | 51 51% of assets are less volatile |
Expected Return
-1.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.19 actual daily | 0 Most of other assets perform better |
Based on monthly moving average PAVmed is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PAVmed by adding PAVmed to a well-diversified portfolio.
Price Book 7.4172 | Enterprise Value Ebitda 3.9106 | Price Sales 2.2726 | Shares Float 8.9 M | Wall Street Target Price 9 |
Related Headline
MaxCyte Headline on 28th of October 2024
Disposition of 3000 shares by Johnston John Joseph of MaxCyt... by Johnston John Joseph
Filed transaction by MaxCyte Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
PAVmed Valuation on October 28, 2024
It is possible to determine the worth of PAVmed on a given historical date. On October 28, 2024 PAVmed was worth 1.11 at the beginning of the trading date compared to the closed value of 1.11. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of PAVmed stock. Still, in general, we apply an absolute valuation method to find PAVmed's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of PAVmed where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against PAVmed's related companies.
Open | High | Low | Close | Volume | |
1.04 | 1.11 | 1.02 | 1.07 | 44,566 | |
10/28/2024 | 1.11 | 1.12 | 1.08 | 1.11 | 25,834 |
1.09 | 1.12 | 1.06 | 1.06 | 20,297 |
Backtest PAVmed | | | PAVmed History | | | PAVmed Valuation | Previous | Next |
PAVmed Trading Date Momentum on October 28, 2024
On October 29 2024 PAVmed Inc was traded for 1.06 at the closing time. The top price for the day was 1.12 and the lowest listed price was 1.06 . The trading volume for the day was 20.3 K. The trading history from October 29, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 4.50% . The trading delta at closing time against the current closing price is 7.21% . |
PAVmed Inc Fundamentals Correlations and Trends
By evaluating PAVmed's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among PAVmed's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. PAVmed financial account trend analysis is a perfect complement when working with valuation or volatility modules.About PAVmed Stock history
PAVmed investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for PAVmed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in PAVmed Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing PAVmed stock prices may prove useful in developing a viable investing in PAVmed
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 7.2 M | 6.9 M | |
Net Loss | -80.3 M | -76.3 M |
PAVmed Stock Technical Analysis
PAVmed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
PAVmed Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
PAVmed Inc cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
PAVmed December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how PAVmed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PAVmed shares will generate the highest return on investment. By undertsting and applying PAVmed stock market strength indicators, traders can identify PAVmed Inc entry and exit signals to maximize returns
PAVmed Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for PAVmed's price direction in advance. Along with the technical and fundamental analysis of PAVmed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of PAVmed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.10) | |||
Jensen Alpha | (0.92) | |||
Total Risk Alpha | (1.72) | |||
Treynor Ratio | (5.64) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.14) | Revenue Per Share 0.459 | Quarterly Revenue Growth 4.898 | Return On Assets (0.80) | Return On Equity (13.58) |
The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.